Actavis, Inc. News Headlines

ACT 
$295.37
*  
1.68
0.57%
Get ACT Alerts
*Delayed - data as of Apr. 20, 2015  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Affordable Pricing Is Driving the Generic Drug Market
3/28/2015 2:05:00 AM - Market Realist


Farallon Capital Increases Position in Covidien
3/28/2015 1:05:00 AM - Market Realist


Farallon Capital Increases Position in Allergan
3/28/2015 1:05:00 AM - Market Realist


Has Orexigen Delivered A Death Knell To Vivus?
3/27/2015 10:37:00 AM - Seeking Alpha






Top Large Cap Stocks That Investors Can Buy Now
3/26/2015 3:20:00 AM - Seeking Alpha




Is a Para IV Filing Rewarding for a Generic Company?
3/25/2015 3:06:00 PM - Market Realist




Why Is the Generics Industry Controlled by Regulations?
3/25/2015 1:05:00 PM - Market Realist










Generics Are Climbing up the Value Chain
3/23/2015 1:05:00 PM - Market Realist


The Federal Reserve: Patient No More?
3/23/2015 11:05:00 AM - Market Realist


What Two Factors Are Driving the US Generics Market?
3/23/2015 9:05:00 AM - Market Realist


5 Rocket Stocks That Are Ready for Blastoff
3/23/2015 8:21:00 AM - TheStreet


Vivus: Qsymia Sales Slip, Company Needs To Shift Into Gear
3/23/2015 6:51:00 AM - Seeking Alpha




Is There Any Potential Left In Horizon Pharma Stock?
3/20/2015 2:55:00 PM - Seeking Alpha